Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomised Controlled Trial Of Hyperfractionated Versus Conventionally Fractionated Radiotherapy In Standard Risk Medulloblastoma

NCT00053872 is registered in ClinicalTrials.gov with University of Leicester as lead sponsor.

NCT NCT00053872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomised Controlled Trial Of Hyperfractionated Versus Conventionally Fractionated Radiotherapy In Standard Risk Medulloblastoma
Lead sponsor
University of Leicester
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2003
Completion date
Not reported
Enrollment
316 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors